HM15211
A Study of Multiple Doses of HM15211(Efocipegtrutide) in Obese Subjects With NAFLD
Hanmi · Phase 1 · Completed · Enrollment 66
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| HM15211 | NAFLD | n/r | n/r | n/r | n/r |
| Placebo | NAFLD | n/r | n/r | n/r | n/r |
Disease Pipeline Tools Obesity
Obesity
Programs, trials, and reported weight change for obesity and overweight.
HM15211
Hanmi · Phase 1 · Completed · Enrollment 66
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| HM15211 | NAFLD | n/r | n/r | n/r | n/r |
| Placebo | NAFLD | n/r | n/r | n/r | n/r |